Aarkstore Enterprise---osiris Therapeutics, Inc. (osir) - Financial And Strategic Analysis Review

Share:    

Osiris Therapeutics, Inc. (Osiris) is a biotechnology company that commercializes stem cell therapeutic products taken from the adult bone marrow. The company is involved in development and sale of various products to treat medical conditions in the inflammatory, orthopedic, and cardiovascular areas. Osteocel, Chondrogen and Prochymal are some of the key products of the company. It has presence across United States and Japan. The company is headquartered in Columbia, the United States. Recently in March 2009, Osiris agreed to transfer its Osteocel business to NuVasive under the asset purchase and manufacturing agreement. In January 2009, the company received U.S.

Osiris Therapeutics, Inc. Key Recent Developments

May 07, 2010: Osiris Therapeutics Reports Net Income Of $2.4 Million In Q1 2010

Feb 24, 2010: Osiris Therapeutics Reports Revenue Of $44.5 Million In 2009

Nov 04, 2009: Osiris Therapeutics Reports Revenues Of $10.6 Million In Q3 2009

Sep 08, 2009: Osiris Therapeutics Declares Preliminary Results For Prochymal Phase III GvHD Trials

Aug 06, 2009: Osiris Therapeutics Reports Revenues Of $10.5 Million In Q2 2009

This comprehensive SWOT analysis of Osiris Therapeutics, Inc. provides you an in-depth strategic analysis of the companys businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the companys key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including,

- Business description A detailed description of the companys operations and business divisions.

- Corporate strategy Analysts summarization of the companys business strategy.

- SWOT Analysis A detailed analysis of the companys strengths, weakness, opportunities and threats.

- Company history Progression of key events associated with the company.

- Major products and services A list of major products, services and brands of the company.

For more information please contact :

http://www.aarkstore.com/reports/Osiris-Therapeutics-Inc-OSIR-Financial-and-Strategic-Analysis-Review-62787.html

http://blogs.aarkstore.com/

From:Aarkstore Enterprise

Contact: Neel

Email: press@aarkstore.com

URL: www.aarkstore.com

by: Aarkstore Enterprise

POST COMMENT

Aarkstore Enterprise---victhom Human Bionics Inc. (vhb) - Financial And Strategic Analysis Review Aarkstore Enterprise---shimadzu Corporation (7701) - Financial And Strategic Analysis Review Aarkstore Enterprise---xcounter Ab (xct) - Financial And Strategic Analysis Review Aarkstore Enterprise---ventracor Limited (vcr) - Financial And Strategic Analysis Review Aarkstore Enterprise---aloka Co., Ltd. (7704) - Financial And Strategic Analysis Review Aarkstore Enterprise---inyx, Inc. (iyxi) - Financial And Strategic Analysis Review Aarkstore Enterprise---moog Inc. (mog.a) - Financial And Strategic Analysis Review Aarkstore Enterprise---biotage Ab (biot) - Financial And Strategic Analysis Review Aarkstore Enterprise---unilens Vision Inc. (uvi) - Financial And Strategic Analysis Review Aarkstore Enterprise---zila, Inc. (zila) - Financial And Strategic Analysis Review Aarkstore Enterprise---hill-rom Holdings, Inc. (hrc) - Financial And Strategic Analysis Review Aarkstore Enterprise---universal Biosensors, Inc. (ubi) - Financial And Strategic Analysis Review Aarkstore Enterprise---itl Limited (itd) - Financial And Strategic Analysis Review